首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Development of 6-Thioguanine conjugated PLGA nanoparticles through thioester bond formation: Benefits of electrospray mediated drug encapsulation and sustained release in cancer therapeutic applications
【24h】

Development of 6-Thioguanine conjugated PLGA nanoparticles through thioester bond formation: Benefits of electrospray mediated drug encapsulation and sustained release in cancer therapeutic applications

机译:通过硫酯键的形成6-硫代阳胺共轭PLGA纳米粒子:电喷雾介导的药物包封和癌症治疗应用中的持续释放的益处

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Polymeric nanoparticle-based successful delivery of hydrophobic drugs is highly desirable for its controlled and sustained release at the disease site, which is a challenge with the current synthesis methods. In the present study, an electrospray mediated facile one-step synthesis approach is explored in which a solution mixture of a hydrophobic drug, 6-thioguanine (Tg) and a biocompatible FDA approved polymer, Poly (d, L-lactide-co-glycolide) (PLGA) is injected in an applied electric field of suitable intensity to prepare drug encapsulated PLGA nanoparticles, PLGA-Tg with high yield. In order to explore the effect of external electric field on Tg loading and delivery applications, the nanoparticles are characterized using EDX, AFM, FESEM, TEM, FTIR, Raman, fluorescence, and mass spectroscopy techniques. The characterization studies indicate that the electric field mediated synthesis exhibits spherical nanoparticles with a homogenous core size distribution of similar to 60 nm, high encapsulation (similar to 97.22%) and stable conjugation of Tg (via thioester linkages) with PLGA molecules in the presence of the applied electric field. The kinetic study demonstrates the 'anomalous diffusion' (non-Fickian diffusion) release mechanism in which Tg escapes from PLGA matrix with a slow, but steady diffusion rate and the sustained drug release profile continues for 60 days. To check the biological activity of the encapsulated Tg, invitro cell studies of the PLGA-Tg are performed on HeLa cells. The MTT assay shows significant cell death after 48 h of treatment, and the cellular internalization of the drug-loaded nanoparticles occurs through pinocytosis mediated uptake, which is established by the AFM analysis. The Raman and mass spectroscopy studies suggest that the PLGA-Tg nanoparticles are rapidly hydrolyzed inside cell cytoplasm to release Tg which initiates apoptosis-mediated cell death confirmed by as DNA fragmentation and membrane blebbing studies. The results clearly emphasize the benefits of electrospray based synthesis of polymeric nanodrug formulation through the formation of chemical bonds between polymer and drug molecules that could be easily implemented in the design and development of an effective nanotherapeutic platform with no typical 'burst effect,' prolonged release profile, and significant toxicity to the cancer cells.
机译:基于聚合物纳米粒子的疏水性药物的成功递送是由于其在疾病部位的控制和持续释放,这是对当前合成方法的攻击。在本研究中,探讨了电拍摄的介导的介导的一步一步合成方法,其中疏水药物,6-硫屈(Tg)和生物相容性FDA批准的聚合物,聚(D,L-丙交酯 - 共乙酰基的溶液混合物)(PLGA)注入应用的合适强度的电场以制备药物包封的PLGA纳米颗粒,PLGA-TG具有高产率。为了探讨外部电场对TG加载和递送应用的影响,纳米颗粒的特征在于使用EDX,AFM,FESEM,TEM,FTIR,拉曼,荧光和质谱技术。表征研究表明,电场介导的合成具有与均匀的芯尺寸分布的球形纳米颗粒,其具有类似于60nm,高封装(类似于97.22%)并在存在下与PLGA分子的Tg(通过硫酯键)稳定缀合应用的电场。动力学研究证明了“异常扩散”(非Fickian扩散)释放机制,其中Tg从PLGA基质逸出,慢,但稳定的扩散速率和持续的药物释放曲线持续60天。为了检查包封Tg的生物活性,PLGA-Tg的invitro细胞研究在Hela细胞上进行。在治疗48小时后,MTT测定显示出显着的细胞死亡,并且通过血细胞蛋白介导的摄取发生的药物负载纳米颗粒的细胞内化,这是由AFM分析建立的。拉曼和质谱研究表明,PLGA-Tg纳米粒子在细胞细胞质内快速水解,释放TG,该TG引发凋亡介导的细胞死亡,通过作为DNA碎片和膜膨胀研究证实。结果清楚地强调了基于电喷雾基于聚合物纳米树脂制剂的益处,通过形成了聚合物和药物分子之间的化学键,这些化合物和药物分子可以在一个有效的纳米治疗平台的设计和开发中容易地实施,没有典型的“突发效应”,延长释放概况和对癌细胞的显着毒性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号